Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

Yildirim, Mahmut EmreKaraca, MustafaArtac, MehmetCicin, IrfanGeredeli, CaglayanAlacacioglu, AhmetSimsek, Eda Tanrikulu2024-04-242024-04-2420220732-183X1527-7755https://hdl.handle.net/11468/23151Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 03-07, 2022 -- ELECTR NETWORK[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.Conference Object4016E15562E15562WOS:000863680303045Q1